Single Dose of 9-cis-retinoic Acid in Hepatic Patients
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To test whether patients with hepatic insufficiency can tolerate one oral dose of
9-cis-retinoic acid and to test whether the metabolism of retinoic acid is altered.